Metagenics, Inc. recalls Spectrazyme, 180 count, 60 count, 12 bottles/case, 20000 tablets/box, 14000 capsules/pail.

Recalled November 20, 2013 · FDA recall F-0138-2014 · Metagenics

Hazard

Metagenics is recalling Spectrazyme because their raw material supplier informed them that enzymes in the blend may contain the antibiotic chloramphenicol. · FDA Class II

Units

1,171,300 units

Sold at

Nationwide in US and worldwide to Japan, Taiwan, Belgium, and Canada

Description

Metagenics is recalling Spectrazyme because their raw material supplier informed them that enzymes in the blend may contain the antibiotic chloramphenicol.

Product

Spectrazyme, 180 count, 60 count, 12 bottles/case, 20000 tablets/box, 14000 capsules/pail.

Manufacturer(s)

Metagenics, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →